BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 11.03.1994

Opportunity for a License: Assay Using Recombinant Histidyl-tRNA Synthetase

The National Institutes of Health seeks to license a novel assay to detect auto-antibodies to histydyl tRNA synthetase, known as JO1, with increased sensitivity for diagnosing autoimmune diseases such as myositis, polymyositis, and dermatomyositis.

Source: Federal Register — Health and Human ServicesOpen original release →